USE OF LONG-LASTING FORMULATIONS OF GLP-1 PEPTIDES AS HYPOGLYCEMIC AGENTS

摘要

The present invention relates to methods and pharmaceutical compositions relating to administering hypoglycemic agents and/or GLP-1 agonists wherein the mean maximum plasma concentration (Cmax) and/or Area Under the Curve (AUC) values of the hypoglycemic agent are increased and/or sustained.